ISB News

Promotion: Dr. Jie Luo Becomes Senior Research Scientist

Congratulations to Dr. Jie Luo, of the Ranish Lab, who has been promoted to senior research scientist. From Dr. Jeff Ranish:

Jie Luo is an extremely dedicated and talented scientist. When he joined ISB in 2006 as a postdoctoral fellow, he had no experience in mass spectrometry-based proteomics. Now he is a leader in the field of structural and functional proteomics. He has conceptualized and implemented several innovative proteomics strategies for studying protein-protein interactions (PPIs) in macromolecular assemblies, and he is currently developing technology to study PPIs on a large scale.  Jie is also quite interactive, collaborating with researchers throughout the world to study the architecture of macromolecular assemblies. A good example of his work can be seen in his recent paper on the architecture of the general transcription and DNA repair factor TFIIH (Luo, et al., Molecular Cell, 2015).

Jie excels at pushing the boundaries of system biology research, and he does it while maintaining a positive attitude. Jie is valuable asset to ISB and it is a pleasure to work with him.

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.